Iverdot 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels in the nerve and muscle cells of invertebrates, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. This medication is primarily indicated for the treatment of strongyloidiasis, onchocerciasis, and other nematode infections. Additionally, Iverdot 12 may be employed off-label for certain ectoparasitic infestations such as scabies and lice. The tablet is administered orally, with dosage and duration tailored according to the specific infection and patient characteristics, including weight and severity of infestation. Ivermectin is generally well-tolerated; however, adverse effects may include dizziness, gastrointestinal disturbances, rash, and transient elevation of liver enzymes. Caution is advised in patients with hepatic impairment or hypersensitivity to the drug. It is contraindicated in children weighing less than 15 kg and in pregnant or breastfeeding women unless clearly needed. Iverdot 12 should be used under medical supervision to ensure appropriate dosing and monitoring for potential side effects or drug interactions.